Skip to main content
Log in

CYP19 gene polymorphism in endometrial cancer patients

  • RAPID COMMUNICATION
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose: Initiation/promotion of endometrial cancer is known to be associated with estrogenic influence. Therefore, it is possible that some allelic polymorphisms of the genes involved in steroidogenesis or steroid metabolism contribute to endometrial cancer susceptibility. Methods: Here, we compared CYP19 (aromatase) gene polymorphism in 85 endometrial cancer patients and in 110 non-affected women. Results: The genotypes containing the longest alleles (A6 and A7) of CYP19 were found to be over-represented in patients as compared to controls. In addition, these genotypes demonstrated a tendency to be associated with increased concentrations of estradiol and testosterone in postmenopausal patients. Conclusions: Thus, CYP19 polymorphism might be one of the genetic risk factors for endometrial cancer development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 20 December 1999 / Accepted: 19 August 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berstein, L., Imyanitov, E., Suspitsin, E. et al. CYP19 gene polymorphism in endometrial cancer patients. J Cancer Res Clin Oncol 127, 135–138 (2001). https://doi.org/10.1007/s004320000200

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004320000200

Navigation